Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma Article

Norden, Andrew D, Raizer, Jeffrey J, Abrey, Lauren E et al. (2010). Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma . JOURNAL OF NEURO-ONCOLOGY, 96(2), 211-217. 10.1007/s11060-009-9948-7

Open Access

cited authors

  • Norden, Andrew D; Raizer, Jeffrey J; Abrey, Lauren E; Lamborn, Kathleen R; Lassman, Andrew B; Chang, Susan M; Yung, WK Alfred; Gilbert, Mark R; Fine, Howard A; Mehta, Minesh; DeAngelis, Lisa M; Cloughesy, Timothy F; Robins, H Ian; Aldape, Kenneth; Dancey, Janet; Prados, Michael D; Lieberman, Frank; Wen, Patrick Y

sustainable development goals

authors

publication date

  • January 1, 2010

published in

keywords

  • CHEMOTHERAPY
  • Clinical Neurology
  • EPIDERMAL-GROWTH-FACTOR
  • EXPRESSION
  • Epidermal growth factor receptor inhibitor
  • Erlotinib
  • FACTOR RECEPTOR
  • GLIOMAS
  • Gefitinib
  • Life Sciences & Biomedicine
  • MULTICENTER
  • Meningioma
  • Neurosciences & Neurology
  • Oncology
  • Science & Technology

Digital Object Identifier (DOI)

publisher

  • SPRINGER

start page

  • 211

end page

  • 217

volume

  • 96

issue

  • 2